Neil Singla Email

Chief Medical Officer . Latigo Biotherapeutics

Thousand Oaks, CA

Location

Current Roles

Employees:
50
Revenue:
$9.5M
About
Latigo Biotherapeutics Inc., headquartered in Thousand Oaks, CA, is a privately held clinical-stage biotechnology company developing best-in-class non-opioid pain medicines that target the fundamental mechanism of pain transduction. The company’s proprietary, in-house technology generates novel drugs against targets validated by human genetics using the most advanced artificial intelligence, machine learning, structure-based, and knowledge-based design techniques to optimize potency and selectivity. The company is backed by top-tier investors, including Westlake Village BioPartners, 5AM Ventures, Foresite Capital, and Corner Ventures.
Latigo Biotherapeutics Address

Thousand Oaks, CA
United States
Latigo Biotherapeutics Email

Past Companies

Lotus Clinical Research, LLCChief Scientific Officer
International Association for the Study of PainChairman, Clinical Trials Special Interest Group
American Pain Society (APS)Chairman, Clinical Trials Shared Interest Group